ADT and CellBounce Announce Arrival of Plug-And-Play Solution to 3G Network Sunset by Summer
BOCA RATON, Fla., May 08, 2020 (GLOBE NEWSWIRE) — ADT (NYSE: ADT), a leading security and automation provider serving residential […]
Gentex Announces Virtual Meeting Format for 2020 Annual Meeting of Shareholders
ZEELAND, Mich., May 08, 2020 (GLOBE NEWSWIRE) — Gentex Corporation (NASDAQ: GNTX), the Zeeland, Michigan-based supplier of digital vision, connected […]
Bio-Path Holdings to Announce First Quarter 2020 Financial Results on May 15, 2020
HOUSTON, May 08, 2020 (GLOBE NEWSWIRE) — Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal […]
Ashish Devalekar Joins Virtusa as Managing Director for Europe and the Middle East
SOUTHBOROUGH, Mass., May 08, 2020 (GLOBE NEWSWIRE) — Virtusa Corporation (NASDAQ GS:VRTU), a global provider of digital strategy, digital engineering, and IT […]
Lithium Americas Reports First Quarter 2020 Results
VANCOUVER, British Columbia, May 08, 2020 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the […]
Lithium Americas Announces Results of 2020 Annual Meeting
VANCOUVER, British Columbia, May 08, 2020 (GLOBE NEWSWIRE) — Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) (“Lithium Americas” or the […]
TSX News -
Dundee Precious Metals Announces Voting Results from 2020 Annual Meeting of Shareholders
TORONTO, May 08, 2020 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX: DPM) (the “Company” or “DPM”) is pleased to […]
Ocugen Provides Business Update and First Quarter 2020 Financial Results
MALVERN, Pa., May 08, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a clinical-stage company focused on discovering, developing and […]
89bio to Present at Upcoming Investor Conferences
SAN FRANCISCO, May 08, 2020 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development […]
Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University to Develop Novel Oligonucleotide Platform for the Treatment of Genetically Driven Cancers
Oncogenuity, Inc., a Fortress partner company, enters into an agreement with Columbia University to develop a broad platform technology using […]
